Quick Answer
10x Genomics, Inc. reported Common Stock Shares Outstanding of 127.69 million shares for the year ending 2025.
- 10x Genomics, Inc. showed an increase of +4.4% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from 10x Genomics, Inc.'s annual report (Form 10-K), filed with the SEC on February 13, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 8 years of available data (2018 to 2025), 10x Genomics, Inc.'s Common Stock Shares Outstanding has grown by 777.6%.
- Historical annual values: Fiscal year 2025: 127.69 million shares | Fiscal year 2024: 122.29 million shares | Fiscal year 2023: 119.10 million shares | Fiscal year 2022: 115.20 million shares | Fiscal year 2021: 112.51 million shares | Fiscal year 2020: 108.49 million shares | Fiscal year 2019: 96.24 million shares | Fiscal year 2018: 14.55 million shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: